Skip to main content
. 2022 Jul 22;10:882416. doi: 10.3389/fped.2022.882416

Table 2.

Demographics, risk factors for EOS and intrapartum antibiotic prophylaxis.

Late preterm neonates (n = 178) Full term neonates (n = 3,267) p All (n = 3,445)
Median gestational age, wks 36.14 (35.29–36.57) 39.71 (39.0–40.29) NA 39.57 (38.86–40.29)
Median birth weight, g 2,582.5 (2,295–2,860) 3,340 (3,060–3,620) NA 3,310 (3,010–3,605)
Vaginal delivery 96 (53.93) 2,565 (78.49) <0.0001 2,661 (77.24)
Prenatal vagino-rectal screening 66 (37.07) 3213 (98.35) <0.0001 3,279 (95.17)
GBS positive screening 13 (19.69) 703 (21.88) 0.7838 716 (21.84)
GBS bacteriuria 0 (0) 46 (1.41) 0.2082 46 (1.34)
Prolonged membrane rupture 41 (23.03) 473 (15.31) 0.0044 514 (15.73)
Maternal temperature ≥ 38° C 2 (0.01) 34 (1.05) 0.9186 36 (1.05)
Previous infant with GBS disease 0 (0) 2 (0.06) 0.2050 2 (0.05)
At least 1 risk factor 178 (100) 503 (15.39) NA 681 (19.77)
IAP 98 (55.05) 923 (28.25) <0.0001 1,021 (29.63)
Adequate IAP 59 (60.20) 516 (55.90) 0.4785 575 (56.32)

GBS, group B streptococcus; IAP, Intrapartum Antibiotic Prophylaxis; NA, not assessable; wks, weeks.

Highest maternal temperature and duration of membrane rupture were missing for 28 (0.8%) (1 preterm, 27 full term) and 178 (5.2%, all full term) cases, respectively. Percentages are calculated without missing cases.

Data are presented as median (IQR) and n (%).